News
Here's Why Developing Countries Can Make mRNA Covid ...
www.nytimes.com
Oct 22, — ... and in many ways is closer to the work of making drugs, said Zoltan Kis, a chemical engineer who analyzed mRNA production capacity for ... › › science › develo...
2021 PDA Innovations in Vaccines Conference - Parenteral ...
www.pda.org
Zoltan Kis, PhD, Research Associate, Imperial College London. 11: :20 | Enabling Accelerated Development - Patient Centric Specifications and ... › event-detail › pda-vaccines...
RNA Vaccine Platforms Have Cost and Speed Advantages
www.genengnews.com
Mar 15, — In terms of overall manufacturing cost, the RNA-based platforms won out, says Zoltan Kis, PhD, from the department of chemical and ... › topics › bioprocessing
Scientists in South Africa attempt to replicate COVID-19 mRNA ...
www.yorkdispatch.com
Oct 24, — Zoltan Kis, an expert in messenger RNA vaccines at Britain's University of Sheffield, said reproducing Moderna's vaccine is “doable” but the ... › story › news ›
sorted by relevance / date